ZOTA Zota Health Care Q4 FY26 results (Jan–Mar 2026) and concall
Zota Health Care reported strong financial performance for FY26, driven by robust growth in its Davaindia retail business, which saw sales nearly double and the store network expand significantly. The company achieved positive EBITDA and substantial gross margin expansion due to its integrated business model. Management plans to moderate store expansion in the near term to prioritize store-level profitability and operational efficiency, while maintaining a long-term vision for continued growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 54.9%, net profit up 134.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 59 | 68 | 78 | 78 | 99 +68% | 109 +60% | 121 +55% |
| EBITDA | 3 | 1 | 4 | 7 | 11 +233% | 8 +531% | 5 +36% |
| Net profit | 2 | 2 | 3 | 6 | 10 +322% | 6 +189% | 6 +134% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
